GUILDFORD, UNITED KINGDOM--(Marketwired - May 3, 2017) -Angle PLC (AIM: AGL) (OTCQX: ANPCY) AIM:AGL OTCQX:ANPCY For immediate release 3 May 2017 ANGLE plc ("the Company") BUSINESS UPDATE HIGHLIGHTS PROGRESS WITH PARSORTIX LIQUID BIOPSY Ovarian cancer clinical studies progressing well wi...Read More
GUILDFORD, UNITED KINGDOM--(Marketwired - Jun 5, 2017) -Angle PLC (AIM: AGL) (OTCQX: ANPCY) AIM:AGL OTCQX:ANPCY For immediate release 5 June 2017 ANGLE plc ("the Company") SUCCESS WITH PARSORTIX IN COLORECTAL CANCER Clinically relevant results presented at ASCO 2017 cancer conference...Read More
GUILDFORD, UNITED KINGDOM--(Marketwired - Jun 15, 2017) -ANGLE plc (AIM: AGL) (OTCQX: ANPCY) AIM: AGL; OTCQX: ANPCY For immediate release 15 June 2017 ANGLE plc ("the Company") PARSORTIX BREAKTHROUGH DELIVERS RARE BLOOD CELL DISCOVERY IN PROSTATE CANCER Barts Cancer Institute study fin...Read More